Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 27827952)

  • 1. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of circulating tumor cells (CTCs) in Egyptian non-metastatic colorectal cancer patients: A comparative study for four different techniques of detection (Flowcytometry, CellSearch, Quantitative Real-time PCR and Cytomorphology).
    Bahnassy AA; Salem SE; Mohanad M; Abulezz NZ; Abdellateif MS; Hussein M; Zekri CAN; Zekri AN; Allahloubi NMA
    Exp Mol Pathol; 2019 Feb; 106():90-101. PubMed ID: 30578762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
    Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
    Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma.
    Man Y; Cao J; Jin S; Xu G; Pan B; Shang L; Che D; Yu Q; Yu Y
    Tohoku J Exp Med; 2014 Sep; 234(1):29-40. PubMed ID: 25175030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells and DNA for real-time EGFR detection and monitoring of non-small-cell lung cancer.
    He J; Tan W; Ma J
    Future Oncol; 2017 Apr; 13(9):787-797. PubMed ID: 28073294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay.
    Li Q; Qi H; Zhou HX; Deng CY; Zhu H; Li JF; Wang XL; Li FR
    Int J Nanomedicine; 2011; 6():2175-81. PubMed ID: 22114481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR.
    Clarke LE; Leitzel K; Smith J; Ali SM; Lipton A
    Int J Oncol; 2003 Feb; 22(2):425-30. PubMed ID: 12527944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer.
    Wang Z; Cai M; Weng Y; Zhang F; Meng D; Song J; Zhou H; Xie Z
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1353-61. PubMed ID: 25544672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells.
    Raynor M; Stephenson SA; Walsh DC; Pittman KB; Dobrovic A
    BMC Cancer; 2002 May; 2():14. PubMed ID: 12031094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroups.
    Lindsay CR; Faugeroux V; Michiels S; Pailler E; Facchinetti F; Ou D; Bluthgen MV; Pannet C; Ngo-Camus M; Bescher G; Caramella C; Billiot F; Remon J; Planchard D; Soria JC; Besse B; Farace F
    Ann Oncol; 2017 Jul; 28(7):1523-1531. PubMed ID: 28633480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients.
    Yang YL; Xu LP; Zhuo FL; Wang TY
    Tumour Biol; 2015 Sep; 36(9):7069-75. PubMed ID: 25869877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.
    Katseli A; Maragos H; Nezos A; Syrigos K; Koutsilieris M
    Clin Lung Cancer; 2013 Sep; 14(5):513-20. PubMed ID: 23810363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and GALC expression of circulating tumor cells indicate metastasis and poor prognosis in non-small cell lung cancer.
    Liu DG; Xue L; Li J; Yang Q; Peng JZ
    Cancer Biomark; 2018; 22(3):417-426. PubMed ID: 29758927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research Advancement on EGFR Mutation Detection of Cell-free DNA and Tumor Cell in Peripheral Blood of Patients with Non-small Cell Lung Cancer].
    Zhang Y; Xu Y; Wang M
    Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):766-772. PubMed ID: 27866520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of chemotherapy-resistant CK19mRNA-positive circulating tumor cells in patients with advanced/metastatic non-small cell lung cancer.
    Milaki G; Messaritakis I; Koinis F; Kotsakis A; Apostolaki S; Dermitzaki EK; Perraki M; Hatzidaki D; Georgoulias V
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):101-108. PubMed ID: 28523597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.